Home
Scientists + Trainees
Learn more about OICR's programs, funding opportunities and careers.
OICR RESEARCHER

If we can do a better job of determining that there is no residual disease after surgery, then we could potentially spare patients adjuvant radiation therapy.
CAREERS@OICR
To learn more about OICR's job opportunities, please visit our Careers page.
Industry
Learn more about OICR's commercialization program, IPDC Fund and investment opportunities.
OICR FUNDED PROJECT

Cellax™ is a drug-polymer conjugate nanoparticle that accumulates in tumours, resulting in increased therapeutic benefits and reduced side effects.
General Public + Media
Learn more about OICR's research, leadership, the latest news items and contact information.






